Study of Biological Activity and Toxicity of Thiosemicarbazides Carbohydrate Derivatives by in Silico, in Vitro and in Vivo Methods
Baktygul Ernazarova1, Taitokur Zhusubaliev1, Zarylkan Asilbek kyzy1, Aida Bakirova1, Gulsara Zhusupbaeva2, Orozby Akparalieva1, Zhypargul Abdullaeva3*orcid, Nasibakhon Razykova1, Asilkan Dzhumanazarova4, Galina Apryshko5, Alina Orozmatova1
1Department of Pharmacy and Medical-Biological Disciplines, Zhalal-Abad State University, Zhalal-Abad, Kyrgyzstan.
2Zhalal-Abad Scientific Center, South Department Academy of Sciences, Zhalal-Abad, Kyrgyzstan.
3Science and Research Department, Osh State University, Osh, Kyrgyzstan.
4Institute of Chemistry and Phytotechnology, National Academy of Sciences, Bishkek, Kyrgyzstan.
5National Medical Research Center of Oncology Named after N.N. Blokhin, Moscow, Russia.
DOI: 10.4236/jacen.2022.111002   PDF    HTML   XML   148 Downloads   816 Views   Citations

Abstract

Computer analysis of N-(β-D-galactopyranosyl)-thiosemicarbazide compounds by in silico method revealed high probability of antibacterial (antimycobacterial), anti-tuberculosis (antituberculosic), antiviral (Influenza), antitumor (antineoplastic) 9 > Pa > 0.5 and with a low probability of cytotoxic/cytostatic (cytostatic/cytotoxic) activities. An experimental study by in vitro and in vivo methods allowed us to conclude that studied new synthetic compound N-(β-D-galactopyranosyl)-thiosemicarbazide in the studied concentrations has a pronounced bactericidal and bacteriostatic effects.

Share and Cite:

Ernazarova, B. , Zhusubaliev, T. , Asilbek kyzy, Z. , Bakirova, A. , Zhusupbaeva, G. , Akparalieva, O. , Abdullaeva, Z. , Razykova, N. , Dzhumanazarova, A. , Apryshko, G. and Orozmatova, A. (2022) Study of Biological Activity and Toxicity of Thiosemicarbazides Carbohydrate Derivatives by in Silico, in Vitro and in Vivo Methods. Journal of Agricultural Chemistry and Environment, 11, 15-23. doi: 10.4236/jacen.2022.111002.

1. Introduction

In recent years, computer programs have been widely used to predict biological activity and toxic effects of organic compounds. Among the programs that can be used to predict various types of biological activity is the PASS program developed by the V.N. Orekhovich RAMS [1].

The use of the PASS program makes it possible, among a wide group of analyzed compounds, to select those that with a high degree of probability have the required types of biological activity and, at the same time, with a low degree of probability, give undesirable toxic effects. When choosing promising compounds, not only main, but also side pharmacological effects were considered.

The fundamental problem of the relationship between the biological activity and the structure of chemical compounds and the search on this basis for new highly active medicinal substances is of fundamental importance for modern pharmacology. For this purpose, we have developed methods for the preparation of carbohydrate derivatives of thiosemicarbazides using the Lawesson reagent [2].

Molecule structure have an important role in the pharmacological activity of thiosemicarbazide derivatives [3], compounds having a pyridine ring and a thiosemicarbazide system as a well-known carrier antituberculosis agent with biological action were synthesized [4].

2. Research Methods and Materials

In this article, study of biological activity and toxicity of thiosemicarbazides carbohydrate derivatives was conducetd by in silico, in vitro and in vivo methods based on our previous works [5] [6]. Acute toxicity of N-(β-D-galactopyranosyl)-thiosemicarbazide was tested in the Biotechnology and Chemistry, Bacteriology Departments of Kyrgyz Republican Center for Diagnostics and Expertise.

3. Results and Discussions

3.1. Possibility Assessment in Using the PASS Сomputer System for Biological Activity

The results of assessing the possibility of using the PASS computer system to predict biological activity by structural formula for chemical compounds as a stage in pre-experimental screening of new substances are presented below. Table 1 shows the results of predicting 14 types of biological activity in the form of values of the probability of presence (Pa) and the probability of absence of this activity (Pi).

With the studied virtual compounds in N-(β-D-galactopyranosyl)-thiosemicarbazide, antibacterial (antimycobacterial), anti-tuberculosic (antituberculosic), antiviral (antiviral (Influenza)), antitumor (antineoplastic >) activity of the compounds are predicted with a high probability (0.9 > 0.5) and with a low probability of cytotoxic/cytostatic (Cytostatic/Cytotoxic) activity. Next, we analyzed possible toxic effects with a probability Pa > 0.5 for compounds 1, 2 based on their structural formulas (Table 2).

The results of computer predictions, we found that compounds 1.2 are predicted to have increased side effects, the ability to cause hyperuricemia an increased level of uric acid in the blood. Among the studied compounds, promising substances for experimental research identified with a high probability of antibacterial activity in N-(β-D-galactopyranosyl)-thiosemicarbazide compounds (Pa/Pi 0.799/0.004 antimycobacterial).

Table 1. Results of glycosylthiosemicarbazides biological activity.

3.2. Studies on Acute Toxicity of N-(β-D-Galactopyranosyl)-Thiosemicarbazide

The acute toxicity of N-(β-D-galactopyranosyl)-thiosemicarbazide was tested in the Biotechnology and Chemistry, Bacteriology Departments of Kyrgyz Republican Center for Diagnostics and Expertise. Study aim of acute toxicity was to determine tolerable, toxic and lethal doses of a pharmacological substance and cause of animals’ death [6].

When studying the toxicology of newly synthesized compounds, the first prerequisite is to determine the parameters of acute toxicity. These indicators are necessary to establish the degree of hazard of a chemical, as well as, for further research, where knowledge of the degree of acute toxicity is required.

Acute toxicity of pharmacological substances [7] [8] is determined by the following parameters: LD0 is the maximum tolerated dose, LD50 is an average lethal dose, LD100 is minimum lethal dose [9]. LD16 and LD84 are also determined to establish the confidence limits of LD50 the average lethal dose.

There are a number of classifications of chemical substances for the assessment of acute toxicity [10] [11] [12]. To assess the toxicity of antiparasitic drugs, the classification according to [12] [13] is more suitable. Based on the foregoing,

Table 2. Results of glycosylthiosemicarbazides toxic effects.

we studied the acute toxicity parameters of a new carbohydrate derivative of thiosemicarbazides N-(β-D-galactopyranosyl)-thiosemicarbazide.

The experiments were carried out on 36 clinically healthy white mice of both sexes with a live weight 18 to 22 grams. The substance was administered to animals orally in the form of a 10% solution using a syringe equipped with a special metal probe, in various doses. Control animals received an appropriate volume of sodium chloride saline solution.

During the experiment, the animals were not limited to feeding and watering. The experiments lasted 12 days, during which the general condition, the nature and degree of chemical toxicity, the time of death of the experimental and control mice were observed. The corpses of the dead experimental animals were subjected to a visual pathoanatomical autopsy to establish the degree and nature of organ damage and the causes of death.

Statistical processing of digital materials was carried out by the method [14], modified [15], using ordinary graph paper [16].

The results of the experiments showed that the nature and degree of chemical toxicity in white mice were in direct proportion to the doses of the studied compound. Signs of poisoning when giving large doses appeared for the first time within minutes and were often fatal within 1 to 2 hours after giving. They were mainly expressed in the manifestation of an excited state (anxiety, increased reaction to external stimuli, tachycardia, rapid breathing), from feed tons of water.

Then this condition passed on to progressive oppression, leading to complete prostration. Breathing is shallow, frequent, and intermittent. Rapid palpitations, sometimes turning into arrhythmias. The death of animals that received large toxic doses of the compound occurred mainly on the first day of administration of the substance. The surviving animals showed mild diarrhea and poor appetite, which soon subsided.

The postmortem autopsy of dead white mice revealed: the back of corpses is soiled with liquid feces; the brain is swollen, hyperemic; the mucous membrane of the stomach and intestines is strongly hyperemic, in some places there are areas of extensive hemorrhage and necrosis; the liver is enlarged, dark red in color, its parenchyma is softened; kidneys of normal size, multiple punctate hemorrhages under the membrane; the heart is flabby, the myocardium is soft, the ventricles contain dark red blood clots, there are punctate hemorrhages on the epicardium and endocardium; the lungs are swollen of a dark red color, the blood vessels are dilated.

The results of statistical processing of digital experimental data showed that (Table 3) the maximum tolerated dose (LD50) of N-(β-D-galactopyranosil)-thiosemicarbazide for white mice was 400 mg/kg, LD16 was 754 mg/kg, the average lethal dose LD50 was 1134 (957 ± 1311) mg/kg, LD84 was 1534 mg/kg and absolutely lethal dose (LD100) was 2000 mg/kg.

Table 3. Acute toxicity parameters of N-(β-D-galactopyranosyl)–thiosemicarbazide tested on mice.

The results obtained indicate that, according to the current classification of the hazard of chemotherapeutic drugs according to the degree of impact on the body (GOST 12.1.007-76), N-(β-D-galactopyranosyl)-thiosemicarbazide belongs to substances of III class of moderate hazard [17] confirms the prospects for further study of this compound in this direction.

3.3. Study of Antibacterial Activity of N-(β-D-Galactopyranosyl)-Thiosemicarbazide

The experiments were carried out at the Department of Biotechnology and Chemistry and at the Department of Bacteriology of the Kyrgyz Republican Center for Diagnostics and Expertise by the in vitro method using generally accepted bacteriology techniques [18] [19] [20] [21] [22].

For this, by means of serial dilutions with distilled water (1:10; 1:20; 1:40 … 1:2650), various concentrations of the substance were prepared, the bactericidal effect of which was studied by plating Salmonella infection of lambs on agar-agar in Petri dishes (Salmonellatyphimurium, 04), salmonellosis of calves (Salmonella Dublin, 09) and colipathogenic serotypes of Escherichia coli (Escherichiacoli 055, 026) and the addition of 0.1 ml of each dilution of the substance.

The results were taken into account after daily cultivation in a thermostat at t = 37˚C, by measuring the diameters of the zones (in mm), and by the absence of microorganism growth at the place where the compound was applied. Distilled water (i.e., solvent) served as a control.

The results of experiments carried out on a solid nutrient medium show (Table 4) that the test compound showed bactericidal activity against the selected microbial cultures, although no pronounced species specificity was observed in its action.

Table 4. Bactericidal activity of N-(β-D-galactopyranosyl)-thiosemicarbazide in a dense nutrient medium (agar-agar).

*numbers show diameter of microorganisms’ growth zones (in mm).

Table 5. Bacteriostatic activity of N-(β-D-galactopyranosyl)-thiosemicarbazide in meat peptone broth.

− lack of growth, + presence of growth.

The bacteriostatic activity of the substance was studied by diluting it in mesopatamia broth at the same concentrations as in the previous experiment, followed by sowing pure cultures in it. The results of this series of experiments showed (Table 5) that the bacteriostatic substance acts on Esch. coli 055 from a dilution of 1:380, for other cultures from a dilution of 1:640.

4. Conclusion

Experiment results after analyses allow concluding, that studied new synthetic compound N-(β-D-galactopyranosyl)-thiosemicarbazide in studied concentrations has a pronounced bactericidal and bacteriostatic effects. Thus, it was proved that experimental study of biological activity coincided with the prediction data, which is an average accuracy of computer prediction with sliding control about 90%.

Conflicts of Interest

The authors declare no conflicts of interest regarding the publication of this paper.

References

[1] Understanding Chemical-Biological Interactions. PASS Online.
http://way2drug.com/PassOnline/index.php
[2] Ernazarova, B.K. (2013) Thionation of Carbohydrate Derivatives of Semicarbazides. Collection of Materials of the XXI International Scientific and Practical Conference “Science and Modernity-2013”, Novosibirsk, 182-186.
[3] Popovici, C., Pavel, C.M., Sunel, V., Cheptea, C., Dimitriu, D.G., Dorohoi, D.O., David, D., et al. (2021) Optimized Synthesis of New Thiosemicarbazide Derivatives with Tuberculostatic Activity. International Journal of Molecular Sciences, 22, Article ID: 12139.
https://doi.org/10.3390/ijms222212139
[4] Pitucha, M., Karczmarzyk, Z., Swatko-Ossor, M., Wysocki, W., Wos, M., Chudzik, K., Ginalska, G. and Fruzinski, A. (2019) Synthesis, in Vitro Screening and Docking Studies of New Thiosemicarbazide Derivatives as Antitubercular Agents. Molecules, 24, Article No. 251.
https://doi.org/10.3390/molecules24020251
[5] Ernazarova, B., Bakirova, A., Dzhumanazarova, A., Abdullaeva, Z., Berkmamatov, S. and Zhusupbaeva, G. (2020) Thionization Method of Glycosyl Urea and Carbamide Sugars. International Journal of Organic Chemistry, 10, 111-122.
https://doi.org/10.4236/ijoc.2020.103008
[6] Ernazarova, B., Dzhumanazarova, A., Bakirova, A., Abdullaeva, Z., Zhusupbaeva, G., Asylbek Kyzy, Z. and Arzybaev, M. (2020) Synthesis, Assessment of Biological Activity and Toxicity for N-(β-D-Glycopyranosyl)-Thiosemicarbazides. International Journal of Organic Chemistry, 10, 159-169.
https://doi.org/10.4236/ijoc.2020.104012
[7] Turner, R.A. (1967) Screening Methods of Pharmacology. Academic Press, New York, 111-112.
[8] Guengerich, F.P. (2011) Mechanisms of Drug Toxicity and Relevance to Pharmaceutical Development. Drug Metabolism and Pharmacokinetics, 26, 3-14.
https://doi.org/10.2133/dmpk.dmpk-10-rv-062
[9] Liakoni, E., Dolder, P.C., Rentsch, K.M. and Liechti, M.E. (2016) Presentations Due to Acute Toxicity of Psychoactive Substances in an Urban Emergency Department in Switzerland: A Case Series. BMC Pharmacology & Toxicology, 17, Article No. 25.
https://doi.org/10.1186/s40360-016-0068-7
[10] Walum, E. (1998) Acute Oral Toxicity. Environmental Health Perspectives, 106, 497-503.
https://doi.org/10.1289/ehp.98106497
[11] Barenboim, G.M. and Malenkov, A.G. (1986) Biological Active Substances. Science, Moscow, 284 p.
[12] Gimenez-Bastida, J.A., Martinez Carreras, L., Moya-Pérez, A. and Laparra Llopis, J.M. (2018) Pharmacological Efficacy/Toxicity of Drugs: A Comprehensive Update about the Dynamic Interplay of Microbes. Journal of Pharmaceutical Sciences, 107, 778-784.
https://doi.org/10.1016/j.xphs.2017.10.031
[13] Belenky, M.L. (1963) Elements of a Quantitative Assessment of the Pharmacological Effect. Science, Leningrad, 146 p.
[14] Albert, A. (1987) Selective Toxicity, Part II. Medicine, Moscow, 49-56.
[15] Sanotsky, I.V. (1970) Methods for Determining the Toxicity and Hazard of Chemicals (Toxicometry). Medicine, Moscow, 219-225.
[16] Sanotsky, I.V. and Ulanova, I.P. (1976) The Criterion of Harm in Hygiene and Toxicology in Assessing the Hazard of Chemical Compounds. Medicine, Moscow, 76-81.
[17] Bear, L.I. (1977) Pesticide Handbook. Harvest, Kiev, 448-450.
[18] Litchfield, J.T. and Wilcoxon, F.J. (1949) Asimplified Method of Evaluating Dose-Effect Experiments. Journal of Pharmacology and Experimental Therapeutics, 96, 99-113.
[19] Roth, Z. (1960) Physiologia Bogtmoslovenica. Praga, 125-128.
[20] Kudrin, A.N. and Ponamareva, G.T. (1967) Application of Mathematics in Experimental and Clinical Medicine. Meditsina Publishers, Moscow, 26-142.
[21] Izmerov, N.F., Sonotsky, N.V. and Sidorov, K.K. (1977) Parameters of Toxometry of Industrial Poisons with a Single Exposure (Reference Book). Medicine, Moscow, 34-36.
[22] Vasiliev, D.A., Shcherbakov, A.A., Karpunina, L.V., Zolotukhin, S.N. and Shvidenko, I.G. (2003) Methods of General Bacteriology. Ulyanovsk, 17-23.

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.